Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts

Reuters
10/17
<a href="https://laohu8.com/S/NVO">Novo Nordisk</a> hires US pharma veteran as Trump pricing pressure mounts

LONDON/COPENHAGEN, Oct 17 (Reuters) - Novo Nordisk NOVOb.CO has appointed U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, according to a statement he posted on LinkedIn, as the obesity drugmaker faces growing pressure from the Trump administration on drug pricing.

Miley, an American, is currently senior vice president of government affairs at U.S. pharmaceutical giant AbbVie ABBV.N. He posted the statement on LinkedIn on Friday and Novo Nordisk shared the statement with Reuters.

(Reporting by Maggie Fick in London and Stine Jacobsen in Copenhagen, Editing by Louise Heavens)

((maggie.fick@thomsonreuters.com; +44 7890 916706;))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10